These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11336617)

  • 1. Clinical review of glimepiride.
    McCall AL
    Expert Opin Pharmacother; 2001 Apr; 2(4):699-713. PubMed ID: 11336617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 1998 Oct; 32(10):1044-52. PubMed ID: 9793597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glimepiride (Amaryl): a review of its pharmacological and clinical profile].
    Bando K; Yamada Y
    Nihon Yakurigaku Zasshi; 2001 Jul; 118(1):59-67. PubMed ID: 11496829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
    Korytkowski MT
    Pharmacotherapy; 2004 May; 24(5):606-20. PubMed ID: 15162895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glimepiride--an oral antidiabetic agent].
    Becić F; Kapić E; Becić E
    Med Arh; 2003; 57(2):125-7. PubMed ID: 12822388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glimepiride in the treatment of type 2 diabetes mellitus.
    Briscoe VJ; Griffith ML; Davis SN
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):225-35. PubMed ID: 20055691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
    Huang HK; Yeh JI
    Diabetes Res Clin Pract; 2019 Jun; 152():103-110. PubMed ID: 31108137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone plus glimepiride: a promising alternative in metabolic control.
    Derosa G
    Int J Clin Pract Suppl; 2007 Jun; (153):28-36. PubMed ID: 17594391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of glimepiride.
    Draeger E
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S139-46. PubMed ID: 8529506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
    Ali Z; Daniyal M; S I I; Usmanghani K; Naveed S
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1443-9. PubMed ID: 27592478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 20. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe.
    Veneman TF; Tack CJ; van Haeften TW
    Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.